Natera (NTRA) Competitors $175.06 +2.90 (+1.68%) Closing price 03:59 PM EasternExtended Trading$174.92 -0.14 (-0.08%) As of 04:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NTRA vs. HIMS, GH, RDNT, OPCH, SHC, BTSG, WGS, CON, PRVA, and SGRYShould you be buying Natera stock or one of its competitors? The main competitors of Natera include Hims & Hers Health (HIMS), Guardant Health (GH), RadNet (RDNT), Option Care Health (OPCH), Sotera Health (SHC), BrightSpring Health Services (BTSG), GeneDx (WGS), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), and Surgery Partners (SGRY). These companies are all part of the "healthcare" industry. Natera vs. Its Competitors Hims & Hers Health Guardant Health RadNet Option Care Health Sotera Health BrightSpring Health Services GeneDx Concentra Group Holdings Parent Privia Health Group Surgery Partners Hims & Hers Health (NYSE:HIMS) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, media sentiment, profitability and analyst recommendations. Do institutionals and insiders believe in HIMS or NTRA? 63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 99.9% of Natera shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by company insiders. Comparatively, 5.6% of Natera shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has higher valuation & earnings, HIMS or NTRA? Hims & Hers Health has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHims & Hers Health$2.01B5.71$126.04M$0.8063.56Natera$1.70B14.16-$190.43M-$1.91-91.65 Do analysts recommend HIMS or NTRA? Hims & Hers Health presently has a consensus price target of $38.92, suggesting a potential downside of 23.47%. Natera has a consensus price target of $194.00, suggesting a potential upside of 10.82%. Given Natera's stronger consensus rating and higher possible upside, analysts plainly believe Natera is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hims & Hers Health 3 Sell rating(s) 8 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.92Natera 0 Sell rating(s) 0 Hold rating(s) 17 Buy rating(s) 1 Strong Buy rating(s) 3.06 Is HIMS or NTRA more profitable? Hims & Hers Health has a net margin of 9.63% compared to Natera's net margin of -12.89%. Hims & Hers Health's return on equity of 26.26% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Hims & Hers Health9.63% 26.26% 13.06% Natera -12.89%-22.22%-15.03% Does the media refer more to HIMS or NTRA? In the previous week, Hims & Hers Health had 1 more articles in the media than Natera. MarketBeat recorded 31 mentions for Hims & Hers Health and 30 mentions for Natera. Natera's average media sentiment score of 1.34 beat Hims & Hers Health's score of 0.54 indicating that Natera is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 9 Very Positive mention(s) 5 Positive mention(s) 9 Neutral mention(s) 6 Negative mention(s) 1 Very Negative mention(s) Positive Natera 22 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, HIMS or NTRA? Hims & Hers Health has a beta of 2.14, suggesting that its stock price is 114% more volatile than the S&P 500. Comparatively, Natera has a beta of 1.68, suggesting that its stock price is 68% more volatile than the S&P 500. SummaryHims & Hers Health beats Natera on 10 of the 17 factors compared between the two stocks. Get Natera News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NTRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NTRA vs. The Competition Export to ExcelMetricNateraMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$24.03B$7.53B$5.70B$10.26BDividend YieldN/A2.80%5.72%4.60%P/E Ratio-91.6574.5675.8826.53Price / Sales14.1635.72492.67165.78Price / CashN/A24.0725.8129.90Price / Book19.347.9012.836.32Net Income-$190.43M$241.92M$3.28B$270.12M7 Day Performance-0.74%0.46%0.17%2.12%1 Month Performance7.38%3.18%4.54%6.31%1 Year Performance35.00%2.56%68.32%25.51% Natera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NTRANatera3.4402 of 5 stars$175.06+1.7%$194.00+10.8%+36.1%$24.03B$1.70B-91.654,434Positive NewsHIMSHims & Hers Health2.6522 of 5 stars$49.77+2.8%$38.92-21.8%+226.0%$11.25B$1.48B62.211,637Trending NewsGHGuardant Health3.9264 of 5 stars$60.17+0.1%$58.24-3.2%+104.5%$7.50B$739.02M-17.962,021Insider TradeRDNTRadNet3.4614 of 5 stars$71.99+0.8%$76.80+6.7%+10.6%$5.54B$1.83B-359.9311,021Positive NewsOPCHOption Care Health4.8688 of 5 stars$29.59+1.7%$35.75+20.8%-12.8%$4.80B$5.00B23.678,088Positive NewsSHCSotera Health2.1579 of 5 stars$15.91+1.9%$16.00+0.6%-3.4%$4.52B$1.10B198.903,000High Trading VolumeBTSGBrightSpring Health Services2.2706 of 5 stars$25.48+5.6%$25.67+0.7%+96.2%$4.51B$12.57B82.2035,000High Trading VolumeWGSGeneDx2.5831 of 5 stars$129.33-2.4%$101.63-21.4%+222.3%$3.72B$305.45M2,586.601,200Positive NewsCONConcentra Group Holdings Parent3.0905 of 5 stars$22.79-1.3%$27.50+20.7%-8.0%$2.92B$1.90B19.1511,250Positive NewsPRVAPrivia Health Group4.4165 of 5 stars$23.59+1.3%$28.58+21.2%+17.9%$2.90B$1.90B214.471,140Positive NewsSGRYSurgery Partners3.2012 of 5 stars$22.08-1.9%$33.00+49.5%-30.3%$2.83B$3.11B-15.4415,000Positive News Related Companies and Tools Related Companies HIMS Competitors GH Competitors RDNT Competitors OPCH Competitors SHC Competitors BTSG Competitors WGS Competitors CON Competitors PRVA Competitors SGRY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NTRA) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored(Please Ignore if Already Rich)Discover how to get access to a weekly livestream with TWO Pro Traders for a full month… And learn their un...Monument Traders Alliance | SponsoredThe End of Elon Musk…?While headlines point to collapsing sales and fading tax credits, tech analyst Jeff Brown says Tesla is on the...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NTRA Stock Alerts